Steven Stein

Steven Stein

Chief Tech/Sci/R&D Officer at INCYTE CORPORATION

Net worth: 8 M $ as of 31/05/2026

59 year
Health Technology
Consumer Services
Finance

Profile

Steven H. Stein holds the position of Chief Medical Officer & Executive Vice President at Incyte Corp. Dr. Stein is also on the board of Kura Oncology, Inc. In his past career Dr. Stein was Vice President-Global Oncology at GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs at Novartis Oncology, Inc. and Senior VP-US Clinical Development & Medical Affair at Novartis Pharmaceuticals Corp. Dr. Stein received a doctorate from the University of the Witwatersrand.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/05/2026 78,327 ( 0.04% ) 8 M $ 31/05/2026

Steven Stein active positions

CompaniesPositionStart
INCYTE CORPORATION Chief Tech/Sci/R&D Officer 02/03/2015
Consultant / Advisor -
Corporate Officer/Principal -

Former positions of Steven Stein

CompaniesPositionEnd
REPARE THERAPEUTICS INC. Director/Board Member 28/01/2026
THESEUS PHARMACEUTICALS, INC. Director/Board Member 14/02/2024
KURA ONCOLOGY, INC. Director/Board Member 01/05/2023
Corporate Officer/Principal 01/02/2015
Corporate Officer/Principal 01/02/2015
See the detail of Steven Stein's experience

Training of Steven Stein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

GlaxoSmithKline (New Jersey)

Finance

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!